ALL >> Business >> View Article
Global Companion Diagnostics Market
Total Articles: 20
Global Companion Diagnostics Market was valued US$ 2.68 Bn in 2017 and is expected to reach US$ 10.76 Bn by 2026, at a CAGR of 18.98 % during a forecast period.
A diagnostic is a process of determining disease, condition, and illness, which clarifies a person symptoms & signs that is useful for an individual's treatment. Companion diagnostic is a medical device that provides important information required for the safety & effective use of a biological product. Companion diagnostics are majorly used in the oncology area due to the growing incidence of cancer and it improvers the focus on cancer research.
Global Companion Diagnostics Market
The important driving factors of the global companion diagnostics market are the rising demand for targeted therapy and the increasing prevalence of cancer. Rising awareness of personalized medicines, growing cases of adverse drug reactions, and co-development of drug & diagnostic technology is also boosting the growth market.
Increasing demand for next-generation sequencing and emerging applications of companion diagnostics in oncology indication provides key opportunities for companion diagnostics market. However, high cost involved in the development of therapeutics & diagnostic tests, and issues related to intellectual property rights is limiting the market growth.
The assay kits & reagents segment accounted for the largest share in the market, owing to its wide range of applications in platforms such as PCR, NGS, IHC, and ISH. Polymerase chain reaction (PCR) is a method widely used in molecular biology to make many copies of a specific DNA segment and is occupied the largest share during the forecast period.
Next-generation sequencing (NGS) is the technology that is used to arrange millions of small fragments of DNA in a line at the same time NGS are capable of processing multiple DNA sequences in parallel. NGS is expected to grow at a high CAGR during the forecast period owing to the availability of next-generation sequencing at low cost, technological advancements and high prevalence of cancer cases.
The supportive government initiatives to promote precision medicine research, along with the strategic alliances between key market players for companion diagnostics test development is expected to hold the largest share in North America followed by Europe throughout the forecast period. Increasing technological advancements aimed at developing companion diagnostic tests for new indications such as neurology, infectious diseases are also expected to hold the largest share in this region. Europe is rising demand for efficiency in healthcare & strengthening healthcare system and Germany is the largest market in Europe due to the presence of major market players and growing demand for technological advancement in these regions. However, Middle East & Africa are estimated to have a limited but stable growth owing to low healthcare expenditure and demand for primary healthcare services in this region.
Key player operating in the global companion diagnostics market are Abbott Laboratories, Agilent Technologies, Inc., ARUP Laboratories, BioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Illumina, Inc., Invivoscribe Technologies, Inc., MolecularMD Corporation, Myriad Genetics, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., ArcherDx, Inc., Exosome Diagnostics, Inc., NeoGenomics, Inc., MDxHealth, Inc., and NanoString Technologies, Inc.
Global Companion Diagnostics Market, by Product and Service:
• Assay kits & reagents
• Software & service
Global Companion Diagnostics Market, by Technology:
• In situ hybridization
• Polymerase chain reaction
• Next-generation sequencing
• Other technologies
Global Companion Diagnostics Market, by Indications:
• Infectious diseases
• Other indications
Global Companion Diagnostics Market, by End-User:
• Pharmaceutical & biopharmaceutical companies
• Reference laboratories
• Other end users
Global Companion Diagnostics Market, by Region:
• North America
• South America
• Middle East & Africa
Key Player Operating In the Global Companion Diagnostics Market:
• Abbott Laboratories
• Agilent Technologies, Inc.
• ARUP Laboratories
• BioMérieux SA
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Illumina, Inc.
• Invivoscribe Technologies, Inc.
• MolecularMD Corporation
• Myriad Genetics, Inc.
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.
• ArcherDx, Inc.
• Exosome Diagnostics, Inc.
• NeoGenomics, Inc.
• MDxHealth, Inc.
• NanoString Technologies, Inc.
Business Articles1. How To Pick Out Best-suited Menu Cover For Your Eatery Store?
2. The Power Of Words: How Words Effect You
Author: EWN Admin
3. Have A Glance On Antique And Vintage Diamond Jewelry Of New York
Author: Steve Son
4. The Mechanism Of Milking
Author: Delmer Group
5. Incredible Benefits Of Ivr Technolgy: I
Author: Surabhi Joshi
6. Buying Your First Cnc Machine
Author: Jaewoo Machines
7. Running Shoes Are Shoes That Are Used For Running Either On Roads Or On Trails Usually. Today Are
8. Mobile And Your Distribution Business
9. Reverse Osmosis And Ro Systems
10. Web Based Manufacturing Erp Software Solution
11. Know Odisha More Closely At Moodisha.org – Uniquely Created Database For Villages Blocks And Distric
12. Innovative Cr Packing Designs, Testing, And Manufacturer
Author: Jack Verhoeff
13. 5 Avoidable Mistakes Of In Laser Engraving
Author: Steven Glassner
14. Rat Guard For Ships – Buying The Best Quality From Online Stores
Author: Robert Smith
15. Automated Email Invoicing Delivery – The Route Of Transformation
Author: Jesse Chris